ESPOO, Finland -- New Finnish deep-tech company aims to make ultra-early disease detection possible through single-molecule protein amplification, enabling the identification of molecular warning signals long before disease becomes clinically visible. The technology has the potential to shift healthcare from reactive treatment to true prevention, extend healthy lifespans, and reduce the global burden of cancer, neurological disorders, and [...]

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® single-cell and bulk RNA-seq NGS solutions SAN JOSE, Calif. -- Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced the launch of the Takara Bio Certified Service Provider [...]

Pre-built connectors link scientific and enterprise tools, including SharePoint, Snowflake, and Notion, to bring full R&D context to AI San Francisco, CA — Benchling today launched AI Connectors, a new set of capabilities built on MCP (Model Context Protocol) that connect scientific data to the growing ecosystem of AI tools used in R&D. The number [...]

Advancing discovery from lab to life through AI-driven insights, imaging, and end-to-end workflows WALTHAM, Mass. — Revvity, Inc. is showcasing its latest innovations in cancer research at the AACR Annual Meeting 2026, to be held in San Diego, April 17-22. The Company’s comprehensive suite of research use only (RUO) oncology solutions are designed to elevate preclinical and translational [...]

Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The new brand structure reflects the scientific journey, connecting early discoveries to translational insight to clinical decision-making. The portfolio brands will debut at the AACR Annual Meeting 2026 and AAI's IMMUNOLOGY 2026™. MINNEAPOLIS -- [...]

Fremont, Calif. – Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced the pricing of its upsized initial public offering of 11,250,000 shares of its common stock at a public offering price of $17.00 per share. In addition, Alamar has granted the underwriters a 30-day option [...]

The PrepQuant™ system automates nucleic acid extraction, concentration, and quantification processes into a single sample preparation run contributing to improving the accuracy, reproducibility, and quality of genomic research PrepQuant™, an integrated nucleic acid extraction system with built-in quantification Tokyo – Hitachi High-Tech Corporation ("Hitachi High-Tech") has jointly developed the PrepQuant™ system ("the system"), an integrated [...]

Recently, Geneus Technologies, a leading domestic company in nanopore sequencing technology, announced the completion of a nearly RMB 100 million B++ round of financing. This round of funding was led by CDBT Group, with participation from Si Chuan Venture Capital. The raised capital will be used to accelerate the commercialization of the world's first "Single-base [...]

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and [...]

DKSH has closed an agreement to acquire the business of Kinematic Resources Sdn. Bhd. (“Kinematic”), a leading Malaysian distributor of high-value scientific and analytical instruments in Malaysia. With this transaction, DKSH Technology further scales its operations in Malaysia in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider [...]